Heribert Juergens - Concepedia

Author

Heribert Juergens

University Hospital Münster

Also Known As

H Juergens, H. Juergens, HERIBERT JUERGENS, Heribert Juergens, Monika Poeppelmann

109

Publications

5.5K

Citations

H-Index

Concepts

All Affiliations

University Hospital Münster University of Münster Emma Kinderziekenhuis Witten/Herdecke University Essen University Hospital

About

Heribert Juergens is an author at University Hospital Münster specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	16	861
2	Cell Biology	5	5	215
3	Immunology	5	5	228
4	Health Sciences	4	4	207
5	Cellular Therapies	1	1	159

Heribert Juergens

Publications

3.3K

Citations

H-Index

Page 1

	Year	Citations
R1507, a Monoclonal Antibody to the Insulin-Like Growth Factor 1 Receptor, in Patients With Recurrent or Refractory Ewing Sarcoma Family of Tumors: Results of a Phase II Sarcoma Alliance for Research Through Collaboration Study Alberto S. Pappo, Shreyaskumar Patel, John Crowley, Journal of Clinical Oncology	2011	318
Preliminary Efficacy of the Anti-Insulin–Like Growth Factor Type 1 Receptor Antibody Figitumumab in Patients With Refractory Ewing Sarcoma Heribert Juergens, Najat C. Daw, Birgit Geoerger, Journal of Clinical Oncology	2011	209
2B4 (CD244) Signaling by Recombinant Antigen-specific Chimeric Receptors Costimulates Natural Killer Cell Activation to Leukemia and Neuroblastoma Cells Bianca Altvater, Silke Landmeier, Sibylle Pscherer, Clinical Cancer Research	2009	200
Cooperative Trial CWS-91 for Localized Soft Tissue Sarcoma in Children, Adolescents, and Young Adults Tobias M. Dantonello, Christoph Int‐Veen, D. Harms, Journal of Clinical Oncology	2009	177
Cyclophosphamide Compared With Ifosfamide in Consolidation Treatment of Standard-Risk Ewing Sarcoma: Results of the Randomized Noninferiority Euro-EWING99-R1 Trial Marie‐Cécile Le Deley, Michael Paulussen, Ian Lewis, Journal of Clinical Oncology	2014	167
The value of local treatment in patients with primary, disseminated, multifocal Ewing sarcoma (PDMES) Julia Haeusler, Andreas Ranft, T. Boelling, Cancer	2009	166
High-Dose Chemotherapy and Blood Autologous Stem-Cell Rescue Compared With Standard Chemotherapy in Localized High-Risk Ewing Sarcoma: Results of Euro-E.W.I.N.G.99 and Ewing-2008 Jeremy Whelan, Marie‐Cécile Le Deley, Uta Dirksen, Journal of Clinical Oncology Localized EsCell TherapySurgical OncologyCancer ManagementPathology	2018	159
The ganglioside antigen GD2 is surface-expressed in Ewing sarcoma and allows for MHC-independent immune targeting Sareetha Kailayangiri, Bianca Altvater, Jutta Meltzer, British Journal of Cancer	2012	140
High-Dose Chemotherapy Compared With Standard Chemotherapy and Lung Radiation in Ewing Sarcoma With Pulmonary Metastases: Results of the European Ewing Tumour Working Initiative of National Groups, 99 Trial and EWING 2008 Uta Dirksen, Bernadette Brennan, Marie‐Cécile Le Deley, Journal of Clinical Oncology	2019	136
Limb Salvage and Outcome of Osteosarcoma Norbert Lindner, Oliver Ramm, Axel Hillmann, Clinical Orthopaedics and Related Research Surgical OncologyLimb ReconstructionOsteopathyMedicineSurgical Pathology	1999	129

Page 1